Answer
Depo-Medrone with Lidocaine can infrequently cause dermal or subdermal atrophy producing skin depressions at the injection site, with possible depigmentation; regeneration is usually complete within a few months or after all steroid crystals have been absorbed.
Sources for this answer
- Depo-Medrone with LidocainePfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 25Document updated
Sources checked